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Summary: In this paper we describe a simple ion Chromatographie
method for determination of oxalate in urine. Acidified urine was
diluted 1 : 2 with 0.03 mol/1 benzidine hydrochloride in 0.3 mol/1
boric acid to precipitate sulphate. The supernatant was passed
through a C18-cartridge and 100 μΐ of eluant were injected into
an ion Chromatographie system. Oxalate was measured by non-
suppressed conductivity detection. The detection limit for urinary
oxalate was 0.05 mmol/1. The recovery for spiked urine samples
was 101.5% with a CV of 4.5%. The within- and between-assay
coefficients of variation were less than 4.5% and 2.5%, respec-
tively. We found the results obtained by this method to be statistic-
ally equivalent to an enzymatic assay and a different ion-chromato-
graphic method.
Introduction
Urolithiasis is still a widespread disease. Almost 70% of the renal
stones consist of two forms of calcium oxalate (1). In addition to
the stone analysis, the reliable analysis of oxalate in body fluids,
especially in urine, is of great importance for the diagnosis and
adequate metaphylaxis of calcium oxalate urolithiasis. In the last
thirty years many methods for the determination of urinary oxalate
have been developed (2, 3). The most applied procedures are color-
imetric methods (4, 5), fluorometry (6), atomic absorption spectro-
photometry (7), gas chromatography (8, 9), isotope dilution (10,
11), enzymatic methods using oxalate oxidase2) (12, 13, 15) or
oxalate decarboxylase2) (14, 15), isotachophoresis (8), and high-
performance liquid chromatography (HPLC), especially ion chro-
matography (13, 16-22). In the last decade both the colorimetric
method by Hodgkinson & Williams (4), which is inaccurate, insen-
sitive, expensive and laborious, and the isotachophoretic method
and gas chromatography have been replaced by specific methods
like enzymatic procedures and HPLC-techniques.
The ion Chromatographie techniques usually apply suppressed con-
ductivity detection of the oxalate ion, although for the oxalate de-
termination in urine, suppression is not required with respect to
sensitivity. We describe a simple oxalate assay using ion chroma-
tography with non-suppressed conductivity detection after removal
of sulphate. The Chromatographie technique, analytical conditions
and its clinical application are reported in this paper.
Materials and Methods
Equipment
The Chromatographie system consisted of an HPLC-pump
(WATERS 510, Waters Chromatography Division, USA), an au-
tosampler (WATERS WISP 712) with variable sample loop, a non-
suppressed conductivity detector (WATERS 431) and an analytical
anion-exchange column (WATERS 1C pak anion high capacity, 4.6
X 140 mm, 10 μηι particle size). Chromatograms were recorded
on an integrator (WATERS Data Module 746). For sample clean-
up SepPak Ci8-plus cartridges (360 mg packing material, 55-105
μηι particle size, Millipore Corp., USA) were used.
Reagents
Boric acid, sodium tetraborate decahydrate, glycerin, n-butanol,
acetonitrile, hydrochloric acid (300 g/kg, about 8 mol/1), ammo-
nium sulphate and ammonium oxalate were obtained from E.
Merck (Darmstadt, Germany); sodium gluconate was purchased
from Sigma (SIGMA Chemical Co., USA) and benzidine dihydro-
chloride from Fluka (Fluka Chemie AG Buchs, Switzerland). All
reagents used were of analytical grade and all solvents were of
HPLC-grade. The 0.03 mol/1 benzidine dihydrochloride/0.3 mol/1
boric acid solution was prepared daily. The stock solution of am-
monium oxalate had a concentration of 0.025 mol/1 and was stor-
able up to one week. The standards were freshly prepared by dilu-
tion of the 25 mmol/1 oxalate stock solution, addition of HC1 (10 ml
8 mol/1 per litre solution), and addition of 20 mmol/1 sulphate. A
0.05 mol/1 ammonium sulphate stock solution was prepared for
precipitation experiments.
Preparation of urine samples
24-h urines were collected in polyethylene bottles containing 15 ml
concentrated hydrochloric acid (300 g/kg) for preservation and to
obtain pH values < 2.0. A 3 ml aliquot of the urine was diluted
with 3 ml of a 0.03 mol/1 benzidine dihydrochloride solution
(CAUTION: highly carcinogenic) in 0.3 mol/1 boric acid, agitated,
and filtrated. A reversed phase C18-cartridge was activated by pass-
ing 2 ml methanol and 4 ml aqua dest. The first millilitre of the
urine sample was rejected and the following 3 ml were collected
in a 4 ml vial.
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Chromatographie conditions
The mobile phase was a borate-gluconate buffer containing 1.47
mmol/1 sodium gluconate, 5.82 mmol/1 boric acid, 1.31 mmol/1
sodium tetraborate decahydrate, 5 ml/1 glycerol, 120 ml/1 acetoni-
trile and 20 ml/1 «-butanol. The eluant had a pH value of 8.5 and
its conductivity was 275 μ8. The flow rate was 2 ml/min. The elu-
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ant was degassed by vacuum filtration through a membrane filter
(0.5 μιη, Millipore Corporation, USA). The detector sensitivity was
set to 0.1 S f ll scale. Pretreated sample material (100 μΐ) was
injected onto the column. The retention time of oxalate was 27
minutes at a constant column temperature of 26 °C. Oxalate was
quantified via peak area and external standards.
The separation column gave reproducible retention times up to 650
injections. After that period a regeneration with 100 ml of twofold
concentrated eluant with a low flow rate < 1.0 ml/min was neces-
sary. After approximately 800 injections the column should be re-
placed.
Results and Discussion
The acidification of the urine samples during collection is often
applied. First of all it prevents oxalate precipitation. Second it de-
lays the formation of oxalate from ascorbate (13, 26). Furthermore,
combined with storage at — 18 °C it is a way of preservation (25).
The interaction of the oxalate peak with the sulphate peak is the
main problem with all anion exchange columns currently available.
This interaction increases the determination limit and disturbs the
accurate evaluation of the oxalate peak area. Experiments to obtain
a better separation of sulphate and oxalate by variation of the
strength of the eluting solvent, the flow rate or the temperature
of the column gave unsatisfying results. Series of measurements
applying solutions with 0.2 mmol/1 of oxalate and varying sulphate
concentrations from 5—35 mmol/1 were performed.· These mea-
surements showed that 20 mmol/1 of sulphate results in deviated
oxalate values. Therefore, it was neccessary to eliminate the sul-
phate.
The first attempts of sulfate precipitation with barium chloride as
suggested by Toyoda (22) were not successful because of a simulta-
neous precipitation of oxalate in the above mentioned concentra-
tion range. Another insoluble sulphate salt is benzidine sulphate
(24). A comparable insoluble oxalate compound should not be
formed under the applied reaction conditions. To investigate this
fact aqueous solutions and urines were treated with aqueous benzi-
dine dihydrochloride solutions with different concentrations to find
the optimal concentration for the quantitative precipitation of sul-
phate. We assumed an average physiological concentration of 20
mmol/1 urinary sulphate. The results of these experiments con-
firmed that the oxalate is not influenced if urines are diluted with
benzidine dihydrochloride solutions with a concentration of 30
mmol/1 in the ratio 1 : 1. To examine the dependency of sulphate
precipitation on the pH value we tested urines with pH values rang-
ing from 1 — 8. We found that pH values ranging from 1—3 were
optimal for the sulphate precipitation and oxalate recovery. A typi-
cal chromatogram before and after precipitation of sulphate is
shown in figure 1.
For the prevention of the oxalate formation from ascorbate by alka-
line pH values during the measurements the urines were diluted
with 0.3 mol/1 boric acid solution as suggested (13, 26). Boric acid
is part of the mobile phase and the pH value of the eluant used
was 8.5 in comparison to pH 10 of the widely used carbonate/
hydrogencarbonate buffer (13, 17). The steps of dilution with boric
acid and the addition of benzidine dihydrochloride were combined
by dissolving the benzidine dihydrochloride in 0.3 mol/1 boric
acid solution.
Other interfering phenomena with ions occuring in urine were not
found. This was tested by adding halogenides, phosphates, ascor-
bate, glyoxylic acid, glycolic acid, and citric acid to acidified stan-
dard solutions in physiological concentrations (23). The calibration
curve for the quantitative determination of oxalate was established
by using aqueous standard solutions with concentrations ranging
from 0.05—1.0 mmol/1. The standards were pretreated and ana-
lyzed analogously to the procedure described for urine samples.
The peak area increases linear with the oxalate concentration in the
range of from 0.05 mmol/1 to 1.0 mmol/1. This range is sufficient,
since 98% of all urine samples are found in this region. The detec-
tion limit for urinary oxalate was 0.05 mmol/1.
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Fig. 1 Typical chromatogram of a 24 h urine containing 0.18
mmol/1 oxalate (A: before separation of sulphate, B: after separa-
tion of sulphate).
To characterize the analytical conditions of the method we eval-
uated the recovery of oxalate added and the within-run and be-
tween-batch precision. To determine the recovery we measured the
urines before and after spiking with oxalate. Oxalate was added to
four urines to obtain an additional oxalate concentration of 0.1,
0.2, 0.3, 0.4, and 0.5 mmol/1, respectively. All 20 samples were
measured twice. In the range from 0.1 to 1.0 mmol/1 oxalate we
found a mean recovery of 101.5% with a CV of 4.5%. Figure 2
shows the recovery results by comparison of expected and mea-
sured oxalate concentration.
For the investigations of between-batch precision three urines with
low, middle and high oxalate concentrations were measured twice
a day over the course of 10 days. Additionally, the oxalate concen-
tration of the same urine sample was determined twenty times to
gain information about within-run precision. The means of oxalate
concentration and the CV are summarized in table 1. These investi-
gations delivered accurate results with oxalate concentrations rang-
ing from 0.1 mmol/1 to 1.0 mmol/1. The CV was best at high and
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Fig. 2 Recovery of the method (solid line = linear regression,
y = 0.9992x - 0.0003).
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Tab. 1 Within-run and between-batch imprecision of the method
(three urine samples with low (A), middle (B), and high (C) oxalate
concentration).
Sample Within-run
B
Between-batch
B
Mean 0.109 0.455 0.729 0.108 0.454 0.702
(mmol/1)
Minimum 0.096 0.402 0.692 0.100 0.438 0.685
(mmol/1)
Maximum 0.137 0.493 0.779 0.116 0.467 0.720
(mmol/1)
Standard devia- 0.008 0.019 0.016 0.006 0.009 0.011
tion (mmol/1)
CV(%) 7.3 4.2 2.2 5.6 2.0 1.6
middle oxalate concentrations. At the concentration of 0.1 mmol/1
the CV was worst but still satisfying.
According to Passing & Bablok (27, 28) we compared the method
described, a different ion Chromatographie method with a more
basic eluant and chemical background supression (13), and a com-
mercial enzymatic kit (Sigma Chemical Co., product No. 591)
using oxalate oxidase (13). This was performed by measuring 80
different urines from healthy subjects and calcium oxalate stone
formers (Department of Urology, University of Bonn) with each of
the methods. Figures 3 and 4 show the correlation between the
three methods compared (regression parameter enzymatic kit —
unsuppressed ion chromatography). The comparison of methods
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Fig. 3 Correlation of the new non-suppressed ion Chromato-
graphie method and the suppressed ion Chromatographie method
(n = 80; solid line: regression according to Passing & Bablok,
y = 0.971x - 0.005).
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Fig. 4 Correlation of the new ion Chromatographie method and
an enzymatic oxalate kit (n = 80; solid line: regression according
to Passing & Bablok, y = 0.983x - 0.012).
showed statistically identical results for all three methods. Because
of the convenience of the method described, it is possible to mea-
sure up to 40 samples per day.
The calculation of cost depends on the amount of samples that are
to be analyzed. The estimated sample-independent charge for the
enzymatic method is about 7 US$ (material, working time, over-
head). Not included in this calculation is the purchase of a photo-
meter, because it is available in most laboratories. The estimated
charges for a suppressed and a non-suppressed ion Chromato-
graphie analysis of oxalate (including purchase, maintenance, and
depreciation of the Chromatographie system) are about 5 US$ and
4 US$. The calculations for the Chromatographie system are based
on a throughput of about 3500 samples/year for 5 years. The higher
expenses for the suppressed system are due to the reduced variety
of suppressor devices and/or suppressed Chromatographie systems.
Conclusions
The HPLC-method for the determination of urinary oxalate is accu-
rate. The results with regard to quality were excellent and the
method is simple to perform. All analytical tests gave accurate re-
sults and the method is very reliable. A comparison with two dif-
ferent well-established procedures showed good correlations. The
problem of interfering sulphate was solved by using a new and
uncomplicated procedure of almost quantitative precipitation of
sulphate using benzidine dihydrochloride. An advantage of the em-
ployed system over other ion Chromatographie methods is the use
of a borate buffer as mobile phase with pH value of 8.5. This
reduces the risk of oxalogenesis from ascorbate. Furthermore, the
method can be adapted to every existing HPLC system.
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